Stock

The shares of Tylenol Maker Kenvue wore a sharp one before the opening bell after us after us President Donald Trump has strengthened uninterrupted and in some cases the distortion relations between Thailanol, vaccines and autism.

“Do not take Tilanol”, Trump issued instructions to pregnant women about ten times during the White House press conference on Monday, and urged mothers not to give their children the medicine, known as acetaminophen in the United States or paracetamol in most other countries.

The shares of New Jersey Consumer Brands fell by 7.5 percent on Monday. The stocks have regained most of those losses early on Tuesday in the pre -market trade.

This announcement, which seemed to be dependent on current studies instead of a large new research, reaches Minister of Health and Humanitarian Services Robert F. Kennedy Junior.The skeptical vaccine provides a healthy American movement again, which focused on what it considers possible reasons for autism.

0:54
The United States will determine the cause of “autism” by September, Kennedy says

Kenfo disagreed with any connection between drugs and unity this week and warned that if pregnant mothers do not use Tilanol when needed, they may face a dangerous option between suffering from fever or the use of more serious alternatives.

Get weekly health news

Receive the latest medical news and health information provided to you every Sunday.

Kenvue was stopped by Johnson & Johnson in 2023. Aside from Tylenol, consumer health company is made FAND-AIDS, Listerine and other home brand names.

Filippo Valney, Citi Investment, has written that he sees a limited danger of new lawsuits after Trump’s announcement, but he believes “there may be a risk to Tilanol consumption given the negative headlines.”

The company has fought hundreds of lawsuits related to the product and its alleged relations with autism, but most of them were rejected.

The analyst expects a positive reaction to Kenfo’s share in the opening bell on Tuesday, given the absence of new scientific evidence.

Kenvue Inc. shares rose. It is based in Summit, New Jersey, more than seven percent in the pre -market trade.

And copied 2025 Canadian press